BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis
Brain · 06.03.2025 · 148 (3) · 908-920
DOI: 10.1093/brain/awae293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 25.09.2024. Verfasst von Caroline Gertrud Bergner und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany. Hauptthemen laut MEDLINE: Remyelination, Oligodendroglia, Multiple Sclerosis, Cerebral Cortex. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Gemeinnützige Hertie-Stiftung, Deutschen Multiple Sklerose Gesellschaft.
Abstract (Originalsprache)
Remyelination is a crucial regenerative process in demyelinating diseases, limiting persisting damage to the CNS. It restores saltatory nerve conduction and ensures trophic support of axons. In patients with multiple sclerosis, remyelination has been observed in both white and grey matter and found to be more efficient in the cortex. Brain-enriched myelin-associated protein 1 (BCAS1) identifies oligodendrocyte lineage cells in the stage of active myelin formation in development and regeneration. Other than in the white matter, BCAS1+ oligodendrocytes are maintained at high densities in the cortex throughout life. Here, we investigated cortical lesions in human biopsy and autopsy tissue from patients with multiple sclerosis in direct comparison to demyelinating mouse models and demonstrate that following a demyelinating insult BCAS1+ oligodendrocytes in remyelinating cortical lesions shift from a quiescent to an activated, internode-forming morphology co-expressing myelin-associated glycoprotein (MAG), necessary for axonal contact formation. Of note, activated BCAS1+ oligodendrocytes are found at early time points of experimental demyelination amidst ongoing inflammation. In human tissue, activated BCAS1+ oligodendrocytes correlate with the density of myeloid cells, further supporting their involvement in an immediate regenerative response. Furthermore, studying the microscopically normal appearing non demyelinated cortex in patients with chronic multiple sclerosis, we find a shift from quiescent BCAS1+ oligodendrocytes to mature, myelin-maintaining oligodendrocytes, suggesting oligodendrocyte differentiation and limited replenishment of BCAS1+ oligodendrocytes in long-standing disease. We also demonstrate that part of perineuronal satellite oligodendrocytes are BCAS1+ and contribute to remyelination in human and experimental cortical demyelination. In summary, our results provide evidence from human tissue and experimental models that BCAS1+ cells in the adult cortex represent a population of pre-differentiated oligodendrocytes that rapidly react after a demyelinating insult thus enabling immediate myelin regeneration. In addition, our data suggest that limited replenishment of BCAS1+ oligodendrocytes may contribute to the remyelination failure observed in the cortex in chronic multiple sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
- Department of Neurology, University Hospital Leipzig, Leipzig 04103, Germany.
- Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens 11528, Greece.
- Institute of Neuronal Cell Biology, Technical University Munich, Munich 81377, Germany.
- Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK.
- Department of Pathology and Immunology, University of Geneva, Geneva 4 1211, Switzerland.
ORCID-Profile: Lisa Schäfer, Imke Metz, Doron Merkler, Christine Stadelmann
Förderung
- Deutsche Forschungsgemeinschaft
- Gemeinnützige Hertie-Stiftung
- Deutschen Multiple Sklerose Gesellschaft
- National Multiple Sclerosis Society
- Ministry for Science and Culture of Lower Saxony
- University Medical Center Göttingen
Zitieren
APA
Bergner, C. G., van der Meer, F., Franz, J., Vakrakou, A., Würfel, T., Nessler, S., Schäfer, L., Nau-Gietz, C., Winkler, A., Lagumersindez-Denis, N., Wrzos, C., Damkou, I. A., Sergiou, C., Schultz, V., Knauer, C., Metz, I., Bahn, E., Garea Rodriguez, E., Merkler, D., …, & Stadelmann, C. (2025). BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis. Brain, 148(3), 908-920. https://doi.org/10.1093/brain/awae293
Vancouver
Bergner CG, van der Meer F, Franz J, Vakrakou A, Würfel T, Nessler S, et al. BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis. Brain. 2025;148(3):908-920. doi:10.1093/brain/awae293
BibTeX
@article{Bergner2025,
author = {Bergner, Caroline Gertrud and van der Meer, Franziska and Franz, Jonas and Vakrakou, Aigli and Würfel, Thea and Nessler, Stefan and Schäfer, Lisa and Nau-Gietz, Cora and Winkler, Anne and Lagumersindez-Denis, Nielsen and Wrzos, Claudia and Damkou, Ioanna Alkmini and Sergiou, Christina and Schultz, Verena and Knauer, Carolin and Metz, Imke and Bahn, Erik and Garea Rodriguez, Enrique and Merkler, Doron and Simons, Mikael and Stadelmann, Christine},
title = {BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis},
journal = {Brain},
year = {2025},
volume = {148},
number = {3},
pages = {908--920},
doi = {10.1093/brain/awae293}
}
EUVIMED